Surmodics - 27 Year Stock Price History | SRDX
Historical daily share price chart and data for Surmodics since 1998 adjusted for splits and dividends. The latest closing stock price for Surmodics as of March 27, 2025 is 30.61.
- The all-time high Surmodics stock closing price was 80.35 on September 13, 2018.
- The Surmodics 52-week high stock price is 42.44, which is 38.6% above the current share price.
- The Surmodics 52-week low stock price is 25.17, which is 17.8% below the current share price.
- The average Surmodics stock price for the last 52 weeks is 36.89.
| Surmodics Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 33.7722 | 39.6800 | 39.7100 | 26.7100 | 30.6100 | -22.70% |
| 2024 | 36.3974 | 35.5600 | 42.2400 | 25.3900 | 39.6000 | 8.94% |
| 2023 | 28.8659 | 33.6100 | 38.5200 | 17.1300 | 36.3500 | 6.54% |
| 2022 | 37.5496 | 49.7200 | 49.7200 | 28.8400 | 34.1200 | -29.14% |
| 2021 | 52.6911 | 44.2500 | 60.3200 | 42.1800 | 48.1500 | 10.64% |
| 2020 | 39.3446 | 40.9600 | 48.7200 | 22.4600 | 43.5200 | 5.04% |
| 2019 | 44.6504 | 46.4100 | 58.3500 | 38.2300 | 41.4300 | -12.34% |
| 2018 | 51.6426 | 28.3500 | 80.3500 | 27.0000 | 47.2600 | 68.79% |
| 2017 | 26.6009 | 25.9000 | 33.2000 | 22.5000 | 28.0000 | 10.24% |
| 2016 | 23.6679 | 18.9900 | 30.4200 | 17.6200 | 25.4000 | 25.31% |
| 2015 | 23.3890 | 22.1100 | 27.2600 | 20.1800 | 20.2700 | -8.28% |
| 2014 | 21.7201 | 24.2600 | 25.7900 | 18.1200 | 22.1000 | -9.39% |
| 2013 | 23.7374 | 23.2100 | 27.5500 | 19.7400 | 24.3900 | 9.08% |
| 2012 | 16.9313 | 14.5200 | 22.3600 | 13.6900 | 22.3600 | 52.52% |
| 2011 | 11.9297 | 11.8300 | 15.4000 | 8.8600 | 14.6600 | 23.50% |
| 2010 | 15.7546 | 23.0000 | 23.0000 | 8.3300 | 11.8700 | -47.62% |
| 2009 | 22.2163 | 25.9900 | 30.6900 | 16.0100 | 22.6600 | -10.33% |
| 2008 | 38.5238 | 54.2800 | 54.2800 | 19.7000 | 25.2700 | -53.44% |
| 2007 | 43.4585 | 32.0500 | 56.7400 | 31.1100 | 54.2700 | 74.39% |
| 2006 | 35.4589 | 37.3700 | 40.2200 | 31.1000 | 31.1200 | -15.87% |
| 2005 | 37.1368 | 31.5500 | 46.1300 | 28.0800 | 36.9900 | 13.78% |
| 2004 | 23.8372 | 24.0800 | 32.9000 | 18.6000 | 32.5100 | 36.94% |
| 2003 | 30.2065 | 29.4900 | 41.0500 | 20.1000 | 23.7400 | -17.22% |
| 2002 | 33.1802 | 35.8000 | 46.5000 | 19.9500 | 28.6800 | -21.34% |
| 2001 | 41.7589 | 31.5000 | 59.3700 | 23.2500 | 36.4600 | -0.95% |
| 2000 | 19.2425 | 15.2500 | 36.8100 | 10.0000 | 36.8100 | 145.40% |
| 1999 | 7.7664 | 6.8750 | 16.0000 | 4.9375 | 15.0000 | 93.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.501B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
| Boston Scientific (BSX) | United States | $154.056B | 41.59 |
| Stryker (SYK) | United States | $148.022B | 31.82 |
| EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
| Medtronic (MDT) | Ireland | $115.624B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
| GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
| Agilent Technologies (A) | United States | $38.594B | 25.57 |
| ResMed (RMD) | United States | $33.728B | 25.98 |
| Terumo (TRUMY) | Japan | $25.984B | 36.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
| Insulet (PODD) | United States | $19.908B | 85.13 |
| Baxter (BAX) | United States | $17.948B | 12.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
| Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
| ICU Medical (ICUI) | United States | $3.924B | 37.35 |
| Envista Holdings (NVST) | United States | $3.683B | 29.30 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.312B | 15.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.822B | 23.71 |
| LeMaitre Vascular (LMAT) | United States | $2.294B | 55.75 |
| Neogen (NEOG) | United States | $2.261B | 26.05 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
| InMode (INMD) | Israel | $1.330B | 11.12 |
| BioLife Solutions (BLFS) | United States | $1.193B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
| CeriBell (CBLL) | United States | $0.911B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
| Evolus (EOLS) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
| Valneva SE (VALN) | France | $0.635B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
| Omeros (OMER) | United States | $0.503B | 0.00 |
| Owens & Minor (OMI) | United States | $0.493B | 3.85 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
| Quanterix (QTRX) | United States | $0.311B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
| OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
| Biote (BTMD) | United States | $0.252B | 5.52 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Zynex (ZYXI) | United States | $0.234B | 49.07 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
| Brainsway (BWAY) | Israel | $0.184B | 97.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| MacroGenics (MGNX) | United States | $0.166B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
| Jin Medical (ZJYL) | China | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.92 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.083B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| Exagen (XGN) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.046B | 13.24 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| INLIF (INLF) | $0.032B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |